直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Webinar

Patent Case Law Developments for Pharmaceutical, Chemical, and Biotech Companies and Practitioners

March 8, 2022

Webinar

Finnegan

View Webinar

Join Finnegan attorneys Justin Hasford, Matthew Hlinka, and Emmanuel Onochie as they explore recent patent case decisions impacting patent protection of innovations in the pharmaceutical, chemical, and biotech fields. Our team will provide guidance for challenges faced by IP owners and advisors, and consider potential solutions. We encourage everyone to join us live or on-demand.

Topics to be discussed include:

  • Proven winning strategies for defeating obviousness challenges in pharmaceutical patent cases
  • The importance of guiding data or information in the prior art when challenging the obviousness of inventions developed in the highly complex pharmaceutical, chemical, and biotech fields
  • The application of the written description requirement to claims reciting functional limitations

Recorded: View On Demand

Moderator:
Emmanuel Onochie

Speakers:
Justin Hasford
Matthew Hlinka

Related Practices

Global IP Enforcement, Litigation, and Trials

Related Industries

Chemicals, Industrials, and Materials

Chemical

Life Sciences

Pharmaceutical

Biotechnology

Related Professionals

Emmanuel N. Onochie
Associate
Washington, DC
+1 202 408 4029
Email
Justin J. Hasford
Partner
Washington, DC
+1 202 408 4175
Email
Matthew J. Hlinka
Partner
Washington, DC
+1 202 408 4333
Email

Related Insights

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass. Patent Litigation Update: April 2026

June 1, 2026

At the PTAB Blog

Claim Disclaimer Derails Instituted IPR in Freightcar America

May 26, 2026

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

Virtual Seminar

Patent "Basics" Seminar

May 19, 2026

Virtual

Federal Circuit IP Blog

When “and” and “e.g.” Matter: Federal Circuit Revives VLSI vs. Intel Case

May 14, 2026

Conference

2026 Advanced Chemical & Biotech Patent Institute

May 11-12, 2026

San Francisco

Workshop

Protecting Innovation in the Life Sciences: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law

May 7, 2026

Cambridge

Panel Discussion

Global Patent Strategies & Litigation: An Exclusive Off-the-Record Conversation with Experienced In-House Leaders

May 5, 2026

London

Articles

D. Mass. Patent Litigation Update, March 2026

D. Mass. Patent Litigation Update: March 2026

May 4, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP